Cyclacel Pharmaceuticals Inc.
13F holders, Q3 2025 (September 30)1holders −14
0new positions
13sold out
$0.25avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Cyclacel Pharmaceuticals Inc. in their 13F filings, down 14 from Q2 2025. 0 opened new positions and 13 sold out. The largest holder was Osaic Holdings, Inc. ($2).
- Company
- Cyclacel Pharmaceuticals Inc.
- CUSIP
- 23254L884
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 13 | $109K |
All 13F filers, Q2 2025 → Q3 2025: 331,805 shares sold, net −331,805 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | No change | 8 | $2 |
"% of holder's portfolio" is CYCLACEL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Cyclacel Pharmaceuticals Inc. the manager owns.